A critical review of the epidemiology of Agent Orange/TCDD and prostate cancer

European Journal of Epidemiology

Volumn 29, Issue 10, 2014, Pages 667-723

  Chang, Ellen T ^a,b   Boffetta, Paolo ^c   Adami, Hans Olov ^d   Cole, Philip ^e   Mandel, Jack S ^a  

^a EXPONENT INC   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Agent Orange; Dioxin; Epidemiology; Prostate cancer; TCDD; Veterans

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; 2,4,5 TRICHLOROPHENOXYACETIC ACID; 2,4 DICHLOROPHENOXYACETIC ACID; POLLUTANT;

CANCER MORTALITY; CANCER RISK; CHEMICAL ANALYSIS; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; HUMAN; INCIDENCE; OCCUPATIONAL ACCIDENT; OCCUPATIONAL EXPOSURE; PROSTATE CANCER; REVIEW; SYSTEMATIC REVIEW; VETERAN; CHEMICALLY INDUCED; EPIDEMIOLOGY; MALE; POLLUTANT; PROSTATIC NEOPLASMS; RISK ASSESSMENT; SOLDIER;

2,4,5-TRICHLOROPHENOXYACETIC ACID; 2,4-DICHLOROPHENOXYACETIC ACID; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; EPIDEMIOLOGIC STUDIES; HUMANS; MALE; MILITARY PERSONNEL; PROSTATIC NEOPLASMS; RISK ASSESSMENT; TETRACHLORODIBENZODIOXIN; VETERANS;

EID: 84912043659     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-014-9931-2     Document Type: Review

References (157)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon: International Agency for Research on Cancer (IARC); 2013 http://globocan.iarc.fr. Accessed 13 June 2014.
2. WCRF, AICR. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Systematic Literature Review Report on Prostate Cancer. Washington, DC: World Cancer Research Fund (WCRF) and American Institute for Cancer Research (AICR); 2007.
3. Huncharek M, Haddock KS, Reid R, Kupelnick B. Smoking as a risk factor for prostate cancer: a meta-analysis of 24 prospective cohort studies. Am J Public Health. 2010;100(4):693–701. doi:10.2105/AJPH.2008.150508.
4. Soto AM, Sonnenschein C. Environmental causes of cancer: endocrine disruptors as carcinogens. Nat Rev Endocrinol. 2010;6(7):363–70. doi:10.1038/nrendo.2010.87.
5. Zafar MB, Terris MK. Prostate cancer detection in veterans with a history of Agent Orange exposure. J Urol. 2001;166(1):100–3.
6. IARC. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 69. Polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans. Lyon: International Agency for Research on Cancer (IARC); 1997.
7. IARC. IARC monographs on the evaluation of carcinogenic risks to humans. Volume 100F. A review of human carcinogens: chemical agents and related occupations. Lyon: International Association for Research on Cancer (IARC); 2012.
8. Bueno de Mesquita HB, Doornbos G, Van der Kuip DA, Kogevinas M, Winkelmann R. Occupational exposure to phenoxy herbicides and chlorophenols and cancer mortality in The Netherlands. Am J Ind Med. 1993;23(2):289–300.
9. Riihimaki V, Asp S, Hernberg S. Mortality of 2,4-dichlorophenoxyacetic acid and 2,4,5-trichlorophenoxyacetic acid herbicide applicators in Finland: first report of an ongoing prospective cohort study. Scand J Work Environ Health. 1982;8(1):37–42.
10. Hogstedt C, Westerlund B. Survey of the death causes in forest workers with and without exposure to phenoxyacid chemicals. Lakartidningen. 1980;77(19):1828–31.
11. USEPA. Exposure and human health reassessment of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related compounds. NAS Review Draft. Washington, DC: United States Environmental Protection Agency (USEPA); 2003.
12. National Research Council. Committee on EPA’s exposure and human health reassessment of TCDD and related compounds. Health risks from dioxin and related compounds: evaluation of the EPA reassessment. Washington, DC: National Academies Press; 2006.
13. National Toxicology Program. 12th report on carcinogens (RoC). Washington, DC: National Institute of Environmental Health Sciences; 2011.
14. WHO. Assessment of the health risk of dioxins: re-evaluation of the tolerable daily intake (TDI). WHO Consultation. Geneva: World Health Organization (WHO); May 25–29, 1998.
15. WHO. Safety evaluation of certain food additives and contaminants. Polychlorinated dibenzodioxins, polychlorinated dibenzofurans, and coplanar polychlorinated biphenyls. WHO Food Additives Series 48. Geneva: World Health Organization (WHO); 2002.
16. ATSDR. Toxicological profile for chlorinated dibenzo-p-dioxins. Atlanta: Agency for Toxic Substances and Disease Registry (ATSDR)1998.
17. Kogevinas M, Becher H, Benn T, et al. Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study. Am J Epidemiol. 1997;145(12):1061–75.
18. Cole P, Trichopoulos D, Pastides H, Starr T, Mandel JS. Dioxin and cancer: a critical review. Regul Toxicol Pharmacol (RTP). 2003;38(3):378–88.
19. Frumkin H. Agent Orange and cancer: an overview for clinicians. CA Cancer J Clin. 2003;53(4):245–55.
20. Steenland K, Bertazzi P, Baccarelli A, Kogevinas M. Dioxin revisited: developments since the 1997 IARC classification of dioxin as a human carcinogen. Environ Health Perspect. 2004;112(13):1265–8.
21. Boffetta P, Mundt KA, Adami HO, Cole P, Mandel JS. TCDD and cancer: a critical review of epidemiologic studies. Crit Rev Toxicol. 2011;41(7):622–36. doi:10.3109/10408444.2011.560141.
22. Tuomisto J, Tuomisto JT. Is the fear of dioxin cancer more harmful than dioxin? Toxicol Lett. 2012;210(3):338–44. doi:10.1016/j.toxlet.2012.02.007.
23. Institute of Medicine. Veterans and Agent Orange: Update 2012. Committee to review the health effects in Vietnam Veterans of exposure to herbicides (ninth biennial update) (prepublication copy: uncorrected proofs). Washington, DC: National Academies Press; 2013.
24. Institute of Medicine. Veterans and Agent Orange: health effects of herbicides used in Vietnam. Committee to review the health effects in Vietnam Veterans of exposure to herbicides. Washington, DC: National Academies Press; 1994.
25. Institute of Medicine. Veterans and Agent Orange: update 1996. Committee to review the health effects in Vietnam veterans of exposure to herbicides. Washington, DC: National Academies Press; 1996.
26. Institute of Medicine. Veterans and Agent Orange: update 1998. Committee to review the health effects in Vietnam veterans of exposure to herbicides (second biennial update). Washington, DC: National Academies Press; 1999.
27. Institute of Medicine. Veterans and Agent Orange: update 2000. Committee to review the health effects in Vietnam veterans of exposure to herbicides (third biennial update). Washington, DC: National Academies Press; 2001.
28. Institute of Medicine. Veterans and Agent Orange: update 2002. Committee to review the health effects in Vietnam veterans of exposure to herbicides (fourth biennial update). Washington, DC: National Academies Press; 2003.
29. Institute of Medicine. Veterans and Agent Orange: update 2004. Committee to review the health effects in Vietnam veterans of exposure to herbicides (fifth biennial update). Washington, DC: National Academies Press; 2005.
30. Institute of Medicine. Veterans and Agent Orange: update 2006. Committee to review the health effects in Vietnam veterans of exposure to herbicides (fifth biennial update). Washington, DC: National Academies Press; 2007.
31. Institute of Medicine. Veterans and Agent Orange: update 2008. Committee to review the health effects in Vietnam Veterans of exposure to herbicides (fifth biennial update). Washington, DC: National Academies Press; 2009.
32. Institute of Medicine. Veterans and Agent Orange: update 2010. Committee to review the health effects in Vietnam veterans of exposure to herbicides (eighth biennial update). Washington, DC: National Academies Press; 2011.
33. Ansbaugh N, Shannon J, Mori M, Farris PE, Garzotto M. Agent Orange as a risk factor for high-grade prostate cancer. Cancer. 2013;119(13):2399–404. doi:10.1002/cncr.27941.
34. Chamie K, DeVere White RW, Lee D, Ok JH, Ellison LM. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer. Cancer. 2008;113(9):2464–70. doi:10.1002/cncr.23695.
35. Etzioni R, Penson DF, Legler JM, et al. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J Natl Cancer Inst. 2002;94(13):981–90.
36. Kvale R, Auvinen A, Adami HO, et al. Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries. J Natl Cancer Inst. 2007;99(24):1881–7. doi:10.1093/jnci/djm249.
37. Brawley OW. Prostate cancer epidemiology in the United States. World J Urol. 2012;30(2):195–200. doi:10.1007/s00345-012-0824-2.
38. Hsing AW, Chokkalingam AP. Prostate cancer epidemiology. Fron Biosci J Virtual Libr. 2006;11:1388–413.
39. Platz EA, Giovannucci E. Chapter 59. Prostate cancer. In: Schottenfeld D, Fraumeni Jr JF, editors. Cancer epidemiology and prevention. 3rd ed. New York: Oxford University Press; 2006. p. 1128–50.
40. Mucci LA, Signorello LB, Adami HO. Chapter 20. Prostate cancer. In: Adami HO, Hunter D, Trichopoulos D, editors. Textbook of cancer epidemiology. 2nd ed. New York: Oxford University Press; 2008. p. 517–54.
41. Patel AR, Klein EA. Risk factors for prostate cancer. Nat Clin Pract Urol. 2009;6(2):87–95. doi:10.1038/ncpuro1290.
42. Eeles R, Goh C, Castro E, et al. The genetic epidemiology of prostate cancer and its clinical implications. Nat Rev Urol. 2014;11(1):18–31. doi:10.1038/nrurol.2013.266.
43. Rota M, Scotti L, Turati F, et al. Alcohol consumption and prostate cancer risk: a meta-analysis of the dose-risk relation. Eur J Cancer Prev. 2012;21(4):350–9. doi:10.1097/CEJ.0b013e32834dbc11.
44. Meyerhardt JA, Ma J, Courneya KS. Energetics in colorectal and prostate cancer. J Clin Oncol. 2010;28(26):4066–73. doi:10.1200/JCO.2009.26.8797.
45. Ragin C, Davis-Reyes B, Tadesse H, et al. Farming, reported pesticide use, and prostate cancer. Am J Men’s Health. 2013;7(2):102–9. doi:10.1177/1557988312458792.
46. Mink PJ, Adami HO, Trichopoulos D, Britton NL, Mandel JS. Pesticides and prostate cancer: a review of epidemiologic studies with specific agricultural exposure information. Eur J Cancer Prev. 2008;17(2):97–110. doi:10.1097/CEJ.0b013e3280145b4c.
47. Hsing AW, Chu LW, Stanczyk FZ. Androgen and prostate cancer: is the hypothesis dead? Cancer Epidemiol Biomark Prev. 2008;17(10):2525–30. doi:10.1158/1055-9965.EPI-08-0448.
48. Hrbacek J, Urban M, Hamsikova E, Tachezy R, Heracek J. Thirty years of research on infection and prostate cancer: no conclusive evidence for a link. A systematic review. Urol Oncol. 2013;31(7):951–65. doi:10.1016/j.urolonc.2012.01.013.
49. Sutcliffe S. Sexually transmitted infections and risk of prostate cancer: review of historical and emerging hypotheses. Future Oncol. 2010;6(8):1289–311. doi:10.2217/fon.10.95.
50. Sutcliffe S, Platz EA. Inflammation in the etiology of prostate cancer: an epidemiologic perspective. Urol Oncol. 2007;25(3):242–9. doi:10.1016/j.urolonc.2006.09.014.
51. Boice JD Jr, Lubin JH. Occupational and environmental radiation and cancer. Cancer Causes Control (CCC). 1997;8(3):309–22.
52. Kohler TS, Fazili AA, Brannigan RE. Putative health risks associated with vasectomy. Urol Clin N Am. 2009;36(3):337–45. doi:10.1016/j.ucl.2009.05.004.
53. Strickler HD, Goedert JJ. Sexual behavior and evidence for an infectious cause of prostate cancer. Epidemiol Rev. 2001;23(1):144–51.
54. Gann PH. Interpreting recent trends in prostate cancer incidence and mortality. Epidemiology. 1997;8(2):117–20.
55. Hankey BF, Feuer EJ, Clegg LX, et al. Cancer surveillance series: interpreting trends in prostate cancer—part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst. 1999;91(12):1017–24.
56. Helgesen F, Holmberg L, Johansson JE, Bergstrom R, Adami HO. Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. J Natl Cancer Inst. 1996;88(17):1216–21.
57. Sun X, Kido T, Okamoto R, et al. The relationship between Agent Orange and prostate specific antigen: a comparison of a hotspot and a non-sprayed area in Vietnam. Environ Health Prev Med. 2013;18(5):356–60. doi:10.1007/s12199-013-0330-1.
58. Kane CJ, Im R, Amling CL, et al. Outcomes after radical prostatectomy among men who are candidates for active surveillance: results from the SEARCH database. Urology. 2010;76(3):695–700. doi:10.1016/j.urology.2009.12.073.
59. Egger M, Schneider M, Davey Smith G. Spurious precision? Meta-analysis of observational studies. BMJ. 1998;316(7125):140–4.
60. Weed DL. Meta-analysis and causal inference: a case study of benzene and non-Hodgkin lymphoma. Ann Epidemiol. 2010;20(5):347–55. doi:10.1016/j.annepidem.2010.02.001.
61. Air Force Health Study. Air Force Health Study comprehensive report. An epidemiologic investigation of health effects in air force personnel following exposure to herbicides. February 1984 to March 2005: prepared for the United States Air Force (USAF) by Science Applications International Corporation (SAIC); 2005.
62. Ketchum NS, Akhtar FZ. The Air Force Health Study. An epidemiologic investigation of health effects in air force personnel following exposure to herbicides. Mortality update 1996. Brooks Air Force Base, Texas: Air Force Materiel Command; 1996.
63. Akhtar FZ, Garabrant DH, Ketchum NS, Michalek JE. Cancer in US Air Force veterans of the Vietnam War. J Occup Environ Med. 2004;46(2):123–36. doi:10.1097/01.jom.0000111603.84316.0f.
64. Ketchum NS, Michalek JE, Burton JE. Serum dioxin and cancer in veterans of Operation Ranch Hand. Am J Epidemiol. 1999;149(7):630–9.
65. Kayajanian GM. Dioxin body burdens in operation ranch hand veterans: promotion blocking and cancer causation. Ecotoxicol Environ Saf. 2001;50(3):167–73. doi:10.1006/eesa.2001.2101.
66. Wolfe WH, Michalek JE, Miner JC, et al. Health status of Air Force veterans occupationally exposed to herbicides in Vietnam. I. Physical health. J Am Med Assoc (JAMA). 1990;264(14):1824–31.
67. Michalek JE, Wolfe WH, Miner JC. Health status of Air Force veterans occupationally exposed to herbicides in Vietnam. II. Mortality. JAMA. 1990;264(14):1832–6.
68. Kramarow EA, Pastor PN. The health of male veterans and nonveterans aged 25–64: United States, 2007–2010. NCHS Data Brief. 2012;101:1–8.
69. McMichael AJ. Standardized mortality ratios and the “healthy worker effect”: scratching beneath the surface. J Occup Med. 1976;18(3):165–8.
70. Stellman JM, Stellman SD, Sommer JF Jr. Utilization, attitudes, and experiences of Vietnam Era veterans with Veterans Administration health facilities: the American Legion experience. Environ Res. 1988;47(2):193–209.
71. Cole SR, Platt RW, Schisterman EF, et al. Illustrating bias due to conditioning on a collider. Int J Epidemiol. 2010;39(2):417–20. doi:10.1093/ije/dyp334.
72. Pavuk M, Michalek JE, Schecter A, Ketchum NS, Akhtar FZ, Fox KA. Did TCDD exposure or service in Southeast Asia increase the risk of cancer in air force Vietnam veterans who did not spray Agent Orange? J Occup Environ Med. 2005;47(4):335–42.
73. Pavuk M, Michalek JE, Ketchum NS. Prostate cancer in US Air Force veterans of the Vietnam War. J Eposure Sci Environ Epidemiol. 2006;16(2):184–90. doi:10.1038/sj.jea.7500448.
74. Gupta A, Ketchum N, Roehrborn CG, Schecter A, Aragaki CC, Michalek JE. Serum dioxin, testosterone, and subsequent risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans. Environ Health Perspect. 2006;114(11):1649–54.
75. Kahn PC, Gochfeld M, Nygren M, Hansson M, Rappe C, Velez H, Ghent-Guenther T, Wilson WP. Dioxins and dibenzofurans in blood and adipose tissue of Agent Orange-exposed Vietnam veterans and matched controls. JAMA. 1988;259(11):1661–7.
76. National Research Council. Assembly of Life Sciences. Panel on the Proposed Air Force Study of Herbicide Orange. Review of U.S. Air Force Protocol: epidemiological investigation of health effects in air force personnel following exposure to herbicide Orange. Washington, DC: National Academies Press; 1980.
77. Institute of Medicine. Disposition of the Air Force Health Study. Washington, DC: National Academies Press; 2006.
78. General Accounting Office. Agent Orange: actions needed to improve communications of Air Force Ranch Hand Study Data and Results. GAO/NSIAD-00-31. Washington, DC: General Accounting Office; 1999.
79. U.S. House of Representatives. Agent Orange: Status of the Air Force Ranch Hand Study: hearing before the subcommittee on National Security, Veterans Affairs, and International Relations of the Committee on Government Reform. 106th Congress. House Hearing 106–163. Washington, DC: U.S. Government Printing Office; 2000.
80. American Legion. Review of the Air Force Health Study: Draft of Critique of Ranch Hand Study. Folder 01, Box 03, Admiral Elmo R. Zumwalt, Jr. Collection: Agent Orange Subject Files, The Vietnam Archive, Texas Tech University; 1991.
81. Buffler PA, Ginevan ME, Mandel JS, Watkins DK. The Air Force health study: an epidemiologic retrospective. Ann Epidemiol. 2011;21(9):673–87. doi:10.1016/j.annepidem.2011.02.001.
82. Centers for Disease Control Veterans Health Studies. Serum 2,3,7,8-tetrachlorodibenzo-p-dioxin levels in US Army Vietnam-era veterans. The Centers for Disease Control Veterans Health Studies. J Am Med Assoc (JAMA). 1988;260(9):1249–54.
83. Lathrop GD, Wolfe WH, Moynahan PM, Albanese RA. Epidemiologic investigation of health effects in air force personnel following exposure to herbicides: study protocol. Initial report for period October 1978–December 1982. Report SAM-TR-82-44. Brooks Air Force Base, Texas: U.S. Air Force School of Aerospace Medicine, Aerospace Medical Division (AFSC); 1982.
84. Thomas TL, Kang HK. Mortality and morbidity among Army Chemical Corps Vietnam veterans: a preliminary report. Am J Ind Med. 1990;18(6):665–73.
85. Kang HK, Dalager NA, Needham LL, et al. Health status of Army Chemical Corps Vietnam veterans who sprayed defoliant in Vietnam. Am J Ind Med. 2006;49(11):875–84. doi:10.1002/ajim.20385.
86. Kang HK, Dalager NA, Needham LL, et al. US Army Chemical Corps Vietnam veterans health study: preliminary results. Chemosphere. 2001;43(4–7):943–9.
87. Cypel Y, Kang H. Mortality patterns of Army Chemical Corps veterans who were occupationally exposed to herbicides in Vietnam. Ann Epidemiol. 2010;20(5):339–46. doi:10.1016/j.annepidem.2010.02.003.
88. U.S. Department of Veterans Affairs. Compensation—veterans exposed to Agent Orange. http://www.benefits.va.gov/compensation/claims-postservice-agent_orange.asp. Last updated 22 October 2013.
89. Young AL, Giesy JP, Jones P, Newton M, Guilmartin JF Jr, Cecil PF Sr. Assessment of potential exposure to Agent Orange and its associated TCDD. Environ Sci Pollut Res Int. 2004;11(6):347–8.
90. Jurek AM, Greenland S, Maldonado G. How far from non-differential does exposure or disease misclassification have to be to bias measures of association away from the null? Int J Epidemiol. 2008;37(2):382–5. doi:10.1093/ije/dym291.
91. Jurek AM, Greenland S, Maldonado G, Church TR. Proper interpretation of non-differential misclassification effects: expectations vs observations. Int J Epidemiol. 2005;34(3):680–7. doi:10.1093/ije/dyi060.
92. Giri VN, Cassidy AE, Beebe-Dimmer J, et al. Association between Agent Orange and prostate cancer: a pilot case–control study. Urology. 2004;63(4):757–60; discussion 60–1. doi:10.1016/j.urology.2003.11.044.
93. Schecter A, Needham L, Pavuk M, et al. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer. Cancer. 2009;115(14):3369–71. doi:10.1002/cncr.24365.
94. Yi SW, Ohrr H, Hong JS, Yi JJ. Agent Orange exposure and prevalence of self-reported diseases in Korean Vietnam Veterans. J Prev Med Public Health. 2013;46(5):213–25. doi:10.3961/jpmph.2013.46.5.213.
95. Stellman JM, Stellman SD, Weber T, Tomasallo C, Stellman AB, Christian R Jr. A geographic information system for characterizing exposure to Agent Orange and other herbicides in Vietnam. Environ Health Perspect. 2003;111(3):321–8.
96. Ginevan ME, Watkins DK, Ross JH, O’Boyle RA. Assessing exposure to allied ground troops in the Vietnam War: a quantitative evaluation of the Stellman Exposure Opportunity Index model. Chemosphere. 2009;75(11):1512–8. doi:10.1016/j.chemosphere.2009.02.014.
97. Yi SW, Ohrr H, Won JU, Song JS, Hong JS. Serum 2,3,7,8-Tetrachlorodibenzo-p-dioxin levels and their association with age, body mass index, smoking, military record-based variables, and estimated exposure to Agent Orange in Korean Vietnam veterans. J Prev Med Public Health. 2013;46(5):226–36. doi:10.3961/jpmph.2013.46.5.226.
98. Li Q, Lan L, Klaassen Z, Shah SR, Moses KA, Terris MK. High level of dioxin-TEQ in tissue is associated with Agent Orange exposure but not with biochemical recurrence after radical prostatectomy. Prostate Cancer Prostatic Dis. 2013. doi:10.1038/pcan.2013.33.
99. Shah SR, Freedland SJ, Aronson WJ, et al. Exposure to Agent Orange is a significant predictor of prostate-specific antigen (PSA)-based recurrence and a rapid PSA doubling time after radical prostatectomy. BJU Int. 2009;103(9):1168–72. doi:10.1111/j.1464-410X.2009.08405.x.
100. Everly L, Merrick GS, Allen ZA, et al. Prostate cancer control and survival in Vietnam veterans exposed to Agent Orange. Brachytherapy. 2009;8(1):57–62. doi:10.1016/j.brachy.2008.08.001.
101. Boyle CA, Decoufle P, Delaney RJ, et al. Postservice mortality among Vietnam veterans. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Services, Centers for Disease Control; 1987.
102. Marshall RP, Jorm AF, Grayson DA, O’Toole BI. Posttraumatic stress disorder and other predictors of health care consumption by Vietnam veterans. Psychiatr Serv (Washington, D.C.). 1998;49(12):1609–11.
103. Schnurr PP, Friedman MJ, Sengupta A, Jankowski MK, Holmes T. PTSD and utilization of medical treatment services among male Vietnam veterans. J Nerv Ment Dis. 2000;188(8):496–504.
104. Virgo KS, Price RK, Spitznagel EL, Ji TH. Substance abuse as a predictor of VA medical care utilization among Vietnam veterans. J Behav Health Serv Res. 1999;26(2):126–39.
105. Australian Institute of Health and Welfare. Health care usage and costs. A comparison of veterans and war widows and widowers with the rest of the community. Canberra, Australia: Australian Institute of Health and Welfare; 2002.
106. Hall W. The logic of a controversy: the case of Agent Orange in Australia. Soc Sci Med. 1989;29(4):537–44.
107. Fett MJ, Adena MA, Cobbin DM, Dunn M. Mortality among Australian conscripts of the Vietnam conflict era. I. Death from all causes. Am J Epidemiol. 1987;125(5):869–77.
108. Wilson EJ, Horsley KW, van der Hoek R. Australian National 1943 Service Vietnam Veterans: mortality and cancer incidence 2005. 1944 Canberra, Australia: Australian Government, Department of Vet-1945 erans’ Affairs, Australian Institute of Health and Welfare; 2005
109. O’Toole BI, Catts SV, Outram S, Pierse KR, Cockburn J. The physical and mental health of Australian Vietnam veterans 3 decades after the war and its relation to military service, combat, and post-traumatic stress disorder. Am J Epidemiol. 2009;170(3):318–30. doi:10.1093/aje/kwp146.
110. Crane PJ, Barnard DL, Horsley KD, Adena MA. Mortality of Vietnam Veterans. The Veteran Cohort Study. A report of the 1996 retrospective cohort study of Australian Vietnam Veterans. Canberra, Australia: Australian Government, Department of Veterans’ Affairs; 1997.
111. Australian Institute of Health and Welfare. Cancer Incidence Study 2003: Australian Veterans of the Korean War. Canberra, Australia: Australian Institute of Health and Welfare 2003.
112. Wilson EJ, Horsley KW, van der Hoek R. The third Australian Vietnam Veterans mortality study 2005. Canberra, Australia: Australian Government, Department of Veterans’ Affairs, Australian Institute of Health and Welfare; 2005.
113. Wilson EJ, Horsley KW, van der Hoek R. Dapsone Exposure and Australian Vietnam Service: Mortality and Cancer Incidence. Canberra, Australia: Australian Government, Department of Veterans' Affairs, Australian Institute of Health and Welfare 2007.
114. Australian Department of Veterans’ Affairs. Morbidity of Vietnam Veterans: a Study of the Health of Australia’s Vietnam Veteran Community: volume 1—male Vietnam Veterans. Survey and community comparison outcomes. Canberra, Australia: Australian Government, Department of Veterans’ Affairs; 1998.
115. Australian Institute of Health and Welfare. Morbidity of Vietnam Veterans. A Study of the Health of Australia’s Vietnam Veteran Community. Volume 3 validation study. Canberra, Australia: Australian Institute of Health and Welfare; 1999.
116. Wilson EJ, Horsley KW, van der Hoek R. Cancer incidence in Australian Vietnam Veterans Study 2005. Canberra, Australia: Australian Government, Department of Veterans’ Affairs, Australian Institute of Health and Welfare; 2005.
117. Boehmer TK, Flanders WD, McGeehin MA, Boyle C, Barrett DH. Postservice mortality in Vietnam veterans: 30-year follow-up. Arch Intern Med. 2004;164(17):1908–16. doi:10.1001/archinte.164.17.1908.
118. Leavy J, Ambrosini G, Fritschi L. Vietnam military service history and prostate cancer. BMC Public Health. 2006;6:75. doi:10.1186/1471-2458-6-75.
119. McBride D, Cox B, Broughton J, Tong D. The mortality and cancer experience of New Zealand Vietnam war veterans: a cohort study. BMJ Open. 2013;3(9):e003379. doi:10.1136/bmjopen-2013-003379.
120. Yi SW. Cancer Incidence in Korean Vietnam Veterans during 1992–2003: the Korean Veterans Health Study. J Prev Med Public Health. 2013;46(6):309–18.
121. Lawrence CE, Reilly AA, Quickenton P, Greenwald P, Page WF, Kuntz AJ. Mortality patterns of New York State Vietnam Veterans. Am J Public Health. 1985;75(3):277–9.
122. Anderson HA, Hanrahan LP, Jensen M, Laurin D, Yick WY, Wiegman P. Wisconsin Vietnam Veteran Mortality Study. Madison, WI: State of Wisconsin, Department of Health and Social Services, Division of Health, Section of Environmental and Chronic Disease Epidemiology; 1986.
123. Holmes AP, Bailey C, Baron RC, et al. West Virginia Vietnam-Era Veterans Mortality Study. Preliminary report. Charleston, WV: West Virginia Health Department; 1986.
124. Visintainer PF, Barone M, McGee H, Peterson EL. Proportionate mortality study of Vietnam-era veterans of Michigan. J Occup Environ Med. 1995;37(4):423–8.
125. Clapp RW, Cupples LA, Colton T, Ozonoff DM. Cancer surveillance of Veterans in Massachusetts, USA, 1982–1988. Int J Epidemiol. 1991;20(1):7–12.
126. Clapp RW. Update of cancer surveillance of veterans in Massachusetts, USA. Int J Epidemiol. 1997;26(3):679–81.
127. Breslin P, Kang HK, Lee Y, Burt V, Shepard BM. Proportionate mortality study of US Army and US Marine Corps veterans of the Vietnam War. J Occup Med. 1988;30(5):412–9.
128. Watanabe KK, Kang HK. Mortality patterns among Vietnam veterans: a 24-year retrospective analysis. J Occup Environ Med. 1996;38(3):272–8.
129. Saracci R, Kogevinas M, Bertazzi PA, et al. Cancer mortality in workers exposed to chlorophenoxy herbicides and chlorophenols. Lancet. 1991;338(8774):1027–32.
130. Neuberger M, Landvoigt W, Derntl F. Blood levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin in chemical workers after chloracne and in comparison groups. Int Arch Occup Environ Health. 1991;63(5):325–7.
131. Flesch-Janys D, Berger J, Gurn P, Manz A, Nagel S, Waltsgott H, Dwyer JH. Exposure to polychlorinated dioxins and furans (PCDD/F) and mortality in a cohort of workers from a herbicide-producing plant in Hamburg, Federal Republic of Germany. Am J Epidemiol. 1995;142(11):1165–75.
132. Manz A, Berger J, Dwyer JH, Flesch-Janys D, Nagel S, Waltsgott H. Cancer mortality among workers in chemical plant contaminated with dioxin. Lancet. 1991;338(8773):959–64.
133. Smith AH, Patterson DG Jr, Warner ML, MacKenzie R, Needham LL. Serum 2,3,7,8-tetrachlorodibenzo-p-dioxin levels of New Zealand pesticide applicators and their implication for cancer hypotheses. J Natl Cancer Inst. 1992;84(2):104–8.
134. Littorin M, Hansson M, Rappe C, Kogevinas M. Dioxins in blood from Swedish phenoxy herbicide workers. Lancet. 1994;344(8922):611–2.
135. Fingerhut MA, Halperin WE, Marlow DA, et al. Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. N Engl J Med. 1991;324(4):212–8. doi:10.1056/nejm199101243240402.
136. Steenland K, Piacitelli L, Deddens J, Fingerhut M, Chang LI. Cancer, heart disease, and diabetes in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Natl Cancer Inst. 1999;91(9):779–86.
137. Collins JJ, Bodner K, Aylward LL, et al. Mortality rates among workers exposed to dioxins in the manufacture of pentachlorophenol. J Occup Environ Med. 2009;51(10):1212–9. doi:10.1097/JOM.0b013e3181badd4e.
138. Collins JJ, Bodner K, Aylward LL, Wilken M, Bodnar CM. Mortality rates among trichlorophenol workers with exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Am J Epidemiol. 2009;170(4):501–6. doi:10.1093/aje/kwp153.
139. Ruder AM, Yiin JH. Mortality of US pentachlorophenol production workers through 2005. Chemosphere. 2011;83(6):851–61. doi:10.1016/j.chemosphere.2011.02.064.
140. ‘t Mannetje A, McLean D, Cheng S, Boffetta P, Colin D, Pearce N. Mortality in New Zealand workers exposed to phenoxy herbicides and dioxins. Occup Environ Med. 2005;62(1):34–40. doi:10.1136/oem.2004.015776.
141. McBride DI, Burns CJ, Herbison GP, Humphry NF, Bodner K, Collins JJ. Mortality in employees at a New Zealand agrochemical manufacturing site. Occup Med (Oxford, England). 2009;59(4):255–63. doi:10.1093/occmed/kqp030.
142. McBride DI, Collins JJ, Humphry NF, et al. Mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin at a trichlorophenol plant in New Zealand. J Occup Environ Med. 2009;51(9):1049–56. doi:10.1097/JOM.0b013e3181b571ae.
143. Boers D, Portengen L, Bueno-de-Mesquita HB, Heederik D, Vermeulen R. Cause-specific mortality of Dutch chlorophenoxy herbicide manufacturing workers. Occup Environ Med. 2010;67(1):24–31. doi:10.1136/oem.2008.044222.
144. Manuwald U, Velasco Garrido M, Berger J, Manz A, Baur X. Mortality study of chemical workers exposed to dioxins: follow-up 23 years after chemical plant closure. Occup Environ Med. 2012;69(9):636–42. doi:10.1136/oemed-2012-100682.
145. Ott MG, Zober A. Cause specific mortality and cancer incidence among employees exposed to 2,3,7,8-TCDD after a 1953 reactor accident. Occup Environ Med. 1996;53(9):606–12.
146. Boers D, Portengen L, Turner WE, Bueno-de-Mesquita HB, Heederik D, Vermeulen R. Plasma dioxin levels and cause-specific mortality in an occupational cohort of workers exposed to chlorophenoxy herbicides, chlorophenols and contaminants. Occup Environ Med. 2012;69(2):113–8. doi:10.1136/oem.2010.060426.
147. Alavanja MC, Samanic C, Dosemeci M, et al. Use of agricultural pesticides and prostate cancer risk in the Agricultural Health Study cohort. Am J Epidemiol. 2003;157(9):800–14.
148. Fritschi L, Glass DC, Tabrizi JS, Leavy JE, Ambrosini GL. Occupational risk factors for prostate cancer and benign prostatic hyperplasia: a case–control study in Western Australia. Occup Environ Med. 2007;64(1):60–5. doi:10.1136/oem.2006.027706.
149. Jones DR, Sutton AJ, Abrams KR, Fenty J, Warren F, Rushton L. Systematic review and meta-analysis of mortality in crop protection product manufacturing workers. Occup Environ Med. 2009;66(1):7–15. doi:10.1136/oem.2007.035733.
150. Consonni D, Pesatori AC, Zocchetti C, et al. Mortality in a population exposed to dioxin after the Seveso, Italy, accident in 1976: 25 years of follow-up. Am J Epidemiol. 2008;167(7):847–58. doi:10.1093/aje/kwm371.
151. Pesatori AC, Consonni D, Rubagotti M, Grillo P, Bertazzi PA. Cancer incidence in the population exposed to dioxin after the “Seveso accident”: twenty years of follow-up. Environ Health. 2009;8:39. doi:10.1186/1476-069x-8-39.
152. Leng L, Chen X, Li CP, Luo XY, Tang NJ. 2,3,7,8-Tetrachlorodibezo-p-dioxin exposure and prostate cancer: a meta-analysis of cohort studies. Public Health. 2014;. doi:10.1016/j.puhe.2013.10.006.
153. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58:295–300.
154. Kociba RJ, Keyes DG, Lisowe RW, et al. Results of a two-year chronic toxicity and oncogenic study of rats ingesting diets containing 2,4,5-trichlorophenoxyacetic acid (2,4,5-T). Food Cosmet Toxicol. 1979;17(3):205–21.
155. Charles JM, Bond DM, Jeffries TK, et al. Chronic dietary toxicity/oncogenicity studies on 2,4-dichlorophenoxyacetic acid in rodents. Fundam Appl Toxicol. 1996;33(2):166–72.
156. Charles JM, Dalgard DW, Cunny HC, Wilson RD, Bus JS. Comparative subchronic and chronic dietary toxicity studies on 2,4-dichlorophenoxyacetic acid, amine, and ester in the dog. Fundam Appl Toxicol. 1996;29(1):78–85.
157. Munro IC, Carlo GL, Orr JC, et al. A comprehensive, integrated review and evaluation of the scientific evidence relating to the safety of the herbicide 2,4-D. Int J Toxicol. 1992;11(5):559–664.